SCHEMBL19373476

SCHEMBL19373476

Cc1cccc2[nH]c(O)cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.62
DDO Q99489 3/20 0.62
FLT3 P36888 3/20 0.49
PDGFRB P09619 1/20 0.49
KIT P10721 1/20 0.49
KIF11 P52732 2/20 0.47
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
CYP2A6 P11509 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MGAM O43451 3/20 0.39
GAA P10253 3/20 0.39
SI P14410 3/20 0.39
MGAM2 Q2M2H8 3/20 0.39
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29713806 0.78 DAO (0.56) DAODDOFLT3PDGFRBKIT
SCHEMBL8230643 0.78 DAO (0.56) DAODDOFLT3PDGFRBKIT
SCHEMBL3423807 0.77 DAO (1.00) DAODDOFLT3PDGFRBKIT
SCHEMBL30939503 0.77 DAO (0.55) DAODDOFLT3PDGFRBKIT
SCHEMBL4071480 0.77 DAO (0.55) DAODDOFLT3PDGFRBKIT
SCHEMBL27289272 0.75 ALDH1A1 (0.41) DAODDOCYP1A2CYP2A6ALDH1A1
SCHEMBL27889601 0.75 DAO (0.62) DAODDOFLT3ALDH1A1IMPDH2
SCHEMBL28115418 0.75 FLT3 (0.49) DAODDOFLT3ALDH1A1HSD17B10
SCHEMBL28114699 0.75 HRH4 (0.44) DAODDOALDH1A1HPGDHSD17B10
SCHEMBL27277840 0.75 DAO (0.62) DAOFLT3CYP1A2CYP2A6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161002-A1 BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE KURA ONCOLOGY, INC. (US) 2017-09-21 WO disclosed
CN-100564375-C (3Z) -3- (2, 3-dihydro-1H-inden-1-ylidene) -1, 3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN INC (US) 2009-12-02 CN disclosed
CN-1250526-C Pyrrole substituted 2-indolinone protein kinase inhibitors SUGEN INC (US) 2006-04-12 CN disclosed
CN-1642944-A (3Z) -3- (2, 3-dihydro-1H-inden-1-ylidene) -1, 3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN INC (US) 2005-07-20 CN disclosed
CN-1541098-A Combination therapy for treatment of cancer �ո��� 2004-10-27 CN disclosed
CN-1349416-A Contraceptive compositions contaiing indoline derivatives and progestational agents AMERICAN HOME PROD (US) 2002-05-15 CN disclosed
CN-1311775-A Pyrrole substituted 2-indolinone protein kinase inhibitors SUGEN INC (US) 2001-09-05 CN disclosed